Franco-Italian company formed on 1 October 2018 by the merger of Essilor and Luxottica, based in Paris and Milan; makes ophthalmic lenses, prescription glasses and sunglasses and is listed on Euronext Paris as EL.
Market cap $87.8B on 21 Nov 2026
| Fundsmith LLP | Terry Smith | 3 | 2025–2026 |
| Third Point | Daniel Loeb | 1 | 2020–2020 |
| Fundsmith Equity Fund Annual Letter to Shareholders 2025 | Terry Smith reports that Fundsmith Equity rose 0.8% in 2025 against 12.8% for the MSCI World Index, in its sixteenth annual letter. | Fundsmith LLP | Terry Smith | 2025 |
| Third Point Q1 2020 Investor Letter | Third Point explains its 16% loss in Q1 2020, the shifts it made to its asset mix and where it sees opportunity after the market turmoil. | Third Point | Daniel Loeb | Q1 2020 |
| Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 | Terry Smith reports Fundsmith Equity's first-half 2025 performance against the MSCI World Index and comparators. | Fundsmith LLP | Terry Smith | 2025 |
| Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2026 | Terry Smith explains changes to how Fundsmith Equity is run after a 2.9% fall in the first half of 2026, and exits 13 holdings including Novo Nordisk, Nike and LVMH. | Fundsmith LLP | Terry Smith | 2026 |
We exited or have started exiting: Atlas Copco, Coloplast, EssilorLuxottica, Intuit, LVMH, Magnum Ice Cream, Mettler-Toledo, Nike, Novo Nordisk, Otis, Unilever, Wolters Kluwer, and Zoetis.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2026 · Fundsmith LLP · page 7 · 2026
During the period we began accumulating stakes in Zoetis, the animal health company, Intuit, the accounting software business and EssilorLuxottica the global eyewear manufacturer and we sold our positions in PepsiCo and Brown-Forman.Show in the letter ›
Fundsmith Equity Fund Semi-Annual Letter to Shareholders 2025 · Fundsmith LLP · page 3 · 2025